---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-000907"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:08:15.466247+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IRADIMED Q4 revenue $19.4M (+11% YoY); raises quarterly dividend to $0.17/share

## Summary
- Q4 revenue record $19.4M (+11% YoY); GAAP EPS $0.40, non-GAAP EPS $0.44.
- Full year 2024 revenue $73.2M (+12% YoY); GAAP EPS $1.50, non-GAAP EPS $1.66.
- Quarterly dividend increased 13% to $0.17/share from $0.15; payable March 5, 2025.
- FY2025 guidance: revenue $78-82M, GAAP EPS $1.55-1.65, non-GAAP EPS $1.71-1.81.
- New Orlando facility on track for mid-2025 completion; ~$5.5M capex remaining in 2025.

## SEC filing metadata
- accession: 0001558370-25-000907
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837025000907/0001558370-25-000907-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837025000907/irmd-20250213x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-000907
- JSON: https://secwatch.observer/filing/0001558370-25-000907.json
- Plain text: https://secwatch.observer/filing/0001558370-25-000907.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.